Home / Street Sector / Analysts Estimate Buzz in Focus: The Dow Chemical Company (NYSE:DOW), Golden Star Resources, Ltd. (NYSE:GSS)

Analysts Estimate Buzz in Focus: The Dow Chemical Company (NYSE:DOW), Golden Star Resources, Ltd. (NYSE:GSS)

The Dow Chemical Company (NYSE:DOW) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.48% to close at $54.07 with the total traded volume of 4.87 Million shares.

Finally, analysts shed their light over the DOW price targets; maintaining price high target of 68.00 while at average the price target was 61.24 in contrast with the current price of 54.07. The price targets are usually acts as the boosters or blasters in the performance of stock. A higher price target would definitely provide confidence to investors during the trading action, consideration given by Wall Street Journal.

So does the rankings given by analysts; let us highlight rankings table and we had 13 analysts recommending BUY ratings for current month and for previous month 13 stands on similar situation; while 5 for the current month as compared to 5 analysts recommending for HOLD from the pool for previous month. While 2 stands at overweight and 1 analyst gave Underweight. For the overall, consensus ratings were for Overweight.

The firm has institutional ownership of 69.30%, while insider ownership included 0.10%. Its price to sales ratio ended at 1.30. DOW attains analyst recommendation of 2.00 with week performance of 1.67%.

Golden Star Resources, Ltd. (NYSE:GSS) [Trend Analysis] moved down reacts as active mover, shares a loss -2.05% to trade at $0.76 and the percentage gap between open changing to regular change was -4.37%.

Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked GSS in recent few months. In ratings table the GSS given BUY ratings by 1″ Analyst in current phase. The 1 number of analyst/s have SELL recommendation for current month on GSS. While 3 number of analysts gave ratings for HOLD in current. As per remarks given by WSJ, overall consensus pool recommend it as Hold security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $0.00 at current month while compared with $0.01 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.05 and on annual basis FY 2016 estimate trends at current was for $-0.02 as compared to one month ago of $0.01, and for next year per share earnings estimates have $0.20.

The firm’s current ratio calculated as 0.50 for the most recent quarter. The firm past twelve months price to sales ratio was 1.74 and price to cash ratio remained 22.27. As far as the returns are concern, the return on equity was recorded as 45.10% and return on investment was -129.20% while its return on asset stayed at -11.80%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Stocks Luring Investors with Juicy Profitability Figures: Oclaro, Inc. (NASDAQ:OCLR), Teradata Corporation (NYSE:TDC)

Oclaro, Inc. (NASDAQ:OCLR) persists its position slightly strong in context of buying side, while shares …

Leave a Reply

Your email address will not be published. Required fields are marked *